A shadow market for unlicensed slimming medications is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.
Experimental Treatment Gaining Popularity Online
Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are urged to contact these profiles directly for source information, while also receiving promotional offers.
Active Trade on Messaging Platforms
Separately, a flourishing market exists on Telegram, where communities with thousands of participants share comparison photos, administration instructions and claims of next-day British shipping. Vendors promote the substance there before directing customers to other platforms for transactions.
Understanding Retatrutide
This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Healthcare Experts Express Concerns
Nevertheless, physicians and chemists have cautions that the sale of what is still an unapproved drug in the UK is a cause for concern and could result in users injecting products of unknown origin.
Several professionals said the demand for retatrutide could be connected to the rising price of approved slimming treatments such as Mounjaro.
Regulatory Status and Implementation
Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for personal consumption under the British medical regulations.
Some influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer laws, risking fines, prosecution or prison.
Service Response and Content Elimination
Based on TikTok, the platform has removed problematic content and banned associated hashtags and search suggestions. The company said it was committed to keeping the platform secure and allocating resources in strengthening enforcement strategies.
Digital Trading Activities
Research also found groups with up to nine thousand members marketing the experimental drug using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with numerous of users, filled with images of weight loss, positive testimonials and detailed instructions for preparing or injecting at residence.
Within minutes of joining one community, a vendor posted WhatsApp details, where the majority of transactions occur. The vendor provided an guidebook and guaranteed delivery within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about body mass, medical conditions or previous experience.
Product Details and Costs
Within these communities, messages show dark colored packages with Royal Mail stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use pens typically priced at £160 for 20mg. When questioned how long a injector should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A representative for Telegram said it regularly monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting substances they cannot confirm. Although the science behind this drug is valid, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.
Her staff has already encountered patients injured by self-injection from unverified sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” said the doctor. “These materials could be impure or improperly measured.”
Manufacturer Statement
A representative from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may expose users to potentially significant medical dangers”.
